Epigenetic Plasticity in Triple-Negative Breast Cancer: Mechanisms of Therapy Resistance, Biomarkers, and Therapeutic Vulnerabilities.

Alaa AR, El-Din SAB, Farrag MA, Ahmed Y, Abdel Aziz ME, Abdel-Ghany S, Arneth B, Sabit H

Open source

DOI
10.3390/biomedicines14092013
Published
2026 Sep 8
Container
Biomedicines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14092013,
  title = {Epigenetic Plasticity in Triple-Negative Breast Cancer: Mechanisms of Therapy Resistance, Biomarkers, and Therapeutic Vulnerabilities.},
  author = {Alaa AR and El-Din SAB and Farrag MA and Ahmed Y and Abdel Aziz ME and Abdel-Ghany S and Arneth B and Sabit H},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14092013},
  url = {https://doi.org/10.3390/biomedicines14092013}
}

RIS

TY  - JOUR
TI  - Epigenetic Plasticity in Triple-Negative Breast Cancer: Mechanisms of Therapy Resistance, Biomarkers, and Therapeutic Vulnerabilities.
AU  - Alaa AR
AU  - El-Din SAB
AU  - Farrag MA
AU  - Ahmed Y
AU  - Abdel Aziz ME
AU  - Abdel-Ghany S
AU  - Arneth B
AU  - Sabit H
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14092013
UR  - https://doi.org/10.3390/biomedicines14092013
ER  - 

APA

AR, A., SAB, E., MA, F., Y, A., ME, A. A., S, A., B, A., & H, S. (2026). Epigenetic Plasticity in Triple-Negative Breast Cancer: Mechanisms of Therapy Resistance, Biomarkers, and Therapeutic Vulnerabilities.. Biomedicines. https://doi.org/10.3390/biomedicines14092013

Source records